Loading company…
Natsar Pharmaceuticals, Inc.
PrivateWon a federal SBIR/STTR research award from HHS and other federal agencies.
Pharmaceuticals
- SEC CIK
- 0002134002
- SAM UEI
- F2KMK7BBBMS3
- Founded
- —Source: [SEC]
- Headquarters
- ELLICOTT CITY, MARYLANDSource: [SEC]
- Headcount
- 5Source: [SEC]
- Stage
- Seed
- Sector
- Healthcare
$4.2MSource: [SEC]Total raised
UndisclosedSource: [SEC]Last valuation
Overview
NATSAR PHARMACEUTICALS, INC. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $1,634,811 in 2025. These are non-dilutive federal research grants, not equity financing. The company is based in ELLICOTT CITY, Maryland.
Funding rounds
2 rounds- SBIR Phase II award (HHS)GrantSep 2025Source: [GOV]$1.6M—post-money
- Private placement (Form D)
Investors
No investors recorded yet for Natsar Pharmaceuticals, Inc..
Add an investorPeople
LeadershipAcquisitions
Natsar Pharmaceuticals, Inc. has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for Natsar Pharmaceuticals, Inc..
Add diversity data